doi: 10.1080/00325481.2021.2002616
Semaglutide stimulates insulin secretion from the pancreas and lowers glucagon secretion, also from the pancreas
Injection Requirement: Despite being only once a week, the need for an injection may be a drawback for patients who prefer oral medications or are uncomfortable with injections
It starts with a 0.25 mg weekly dose, which can be adjusted based on how well it works for each person
The study was designed to rule out an 80% excess risk of MACE compared with placebo, which it successfully demonstrated
Liraglutide vs Semaglutide vs GLP-1 for weight loss Liraglutide, Semaglutide, and GLP-1 receptor agonists are effective medications designed for weight loss, each with unique characteristics and benefits